ASX Limited (AUX.F)
| Previous Close | 53.00 |
| Open | 54.50 |
| Bid | 54.50 x 17000 |
| Ask | 56.50 x 16200 |
| Day's Range | 53.00 - 53.00 |
| 52 Week Range | 46.20 - 60.00 |
| Volume | |
| Avg. Volume | 4 |
| Market Cap | 10.697B |
| Beta (5Y Monthly) | 0.18 |
| PE Ratio (TTM) | 32.38 |
| EPS (TTM) | 1.68 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.58 (2.89%) |
| Ex-Dividend Date | Mar 03, 2022 |
| 1y Target Est | N/A |
- GlobeNewswire
Lyell Immunopharma to Present Preclinical Data for Two Product Candidates in Clinical Development at ASGCT Annual Meeting
SOUTH SAN FRANCISCO, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc., (Nasdaq: LYEL), a T-cell reprogramming company dedicated to the mastery of T cells to cure patients with solid tumors, announced today that two abstracts have been accepted for poster presentations at the 25th Annual Meeting of the American Society of Gene & Cell Therapy, scheduled for May 16 - May 19, 2022, in Washington, DC. The presentations will highlight preclinical data characterizing two investigationa
- Simply Wall St.
ASX's (ASX:ASX) 15% CAGR outpaced the company's earnings growth over the same five-year period
Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...
- ABN Newswire
Australia Sunny Glass Group Ltd (AG1.NSX) Proposes to List on the Australian Securities Exchange
Australia Sunny Glass Group Limited (NSX:AG1) advises that it has commenced preparations to make an application for admission to the Official List of the Australian Securities Exchange and proposes to undertake a public offer to raise additional capital in support of its application.
